Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rigel Pharmaceuticals Inc...

    NASDAQ: RIGL · Real-Time Price · USD
    19.18
    -1.25 (-6.12%)
    At close: Jun 17, 2025, 3:59 PM
    19.45
    1.38%
    After-hours: Jun 17, 2025, 07:11 PM EDT

    Rigel Pharmaceuticals Statistics

    Share Statistics

    Rigel Pharmaceuticals has 17.87M shares outstanding. The number of shares has increased by 1.74% in one year.

    Shares Outstanding

    n/a
    		 17.87M

    Shares Change (YoY)

    n/a
    		 1.74%

    Shares Change (QoQ)

    n/a
    		 1.41%

    Owned by Institutions (%)

    n/a
    		 68.66%

    Shares Floating

    n/a
    		 17.37M

    Failed to Deliver (FTD) Shares

    n/a
    		 251

    FTD / Avg. Volume

    n/a
    		 0.12%

    Short Selling Information

    The latest short interest is 1.99M, so 11.12% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.99M

    Short % of Shares Out

    n/a
    		 11.12%

    Short % of Float

    n/a
    		 11.43%

    Short Ratio (days to cover)

    n/a
    		 9.23

    Valuation Ratios

    The PE ratio is 16.91 and the forward PE ratio is 10.93. Rigel Pharmaceuticals's PEG ratio is -0.1.

    PE Ratio

    n/a
    		 16.91

    Forward PE

    n/a
    		 10.93

    PS Ratio

    n/a
    		 1.65

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 89.93

    P/FCF Ratio

    n/a
    		 9.41

    PEG Ratio

    n/a
    		 -0.1
    Financial Ratio History

    Enterprise Valuation

    Rigel Pharmaceuticals has an Enterprise Value (EV) of 298.9M.

    EV / Sales

    n/a
    		 1.67

    EV / EBITDA

    n/a
    		 10.48

    EV / EBIT

    n/a
    		 9.5

    EV / FCF

    n/a
    		 9.51

    Financial Position

    The company has a current ratio of 2.13, with a Debt / Equity ratio of 18.24.

    Current Ratio

    n/a
    		 2.13

    Quick Ratio

    n/a
    		 2.04

    Debt / Equity

    n/a
    		 18.24

    Debt / EBITDA

    n/a
    		 2.1

    Debt / FCF

    n/a
    		 1.91

    Interest Coverage

    n/a
    		 3.06

    Financial Efficiency

    Return on Equity is 531.78% and Return on Invested Capital is 21.28%.

    Return on Equity

    n/a
    		 531.78%

    Return on Assets

    n/a
    		 10.66%

    Return on Invested Capital

    n/a
    		 21.28%

    Revenue Per Employee

    n/a
    		 $1,106,654.32

    Profits Per Employee

    n/a
    		 $107,932.1

    Employee Count

    n/a
    		 162

    Asset Turnover

    n/a
    		 1.09

    Inventory Turnover

    n/a
    		 3.11

    Taxes

    Income Tax

    n/a
    		 881K

    Effective Tax Rate

    n/a
    		 4.8%

    Stock Price Statistics

    The stock price has increased by 120.3% in the last 52 weeks. The beta is 1.29, so Rigel Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.29

    52-Week Price Change

    n/a
    		 120.3%

    50-Day Moving Average

    n/a
    		 19.04

    200-Day Moving Average

    n/a
    		 18.86

    Relative Strength Index (RSI)

    n/a
    		 52.42

    Average Volume (20 Days)

    n/a
    		 215,898

    Income Statement

    In the last 12 months, Rigel Pharmaceuticals had revenue of 179.28M and earned 17.48M in profits. Earnings per share was 0.99.

    Revenue

    n/a
    		 179.28M

    Gross Profit

    n/a
    		 160.63M

    Operating Income

    n/a
    		 24.19M

    Net Income

    n/a
    		 17.48M

    EBITDA

    n/a
    		 28.51M

    EBIT

    n/a
    		 26.28M

    Earnings Per Share (EPS)

    n/a
    		 0.99
    Full Income Statement

    Balance Sheet

    The company has 56.75M in cash and 59.97M in debt, giving a net cash position of -3.22M.

    Cash & Cash Equivalents

    n/a
    		 56.75M

    Total Debt

    n/a
    		 59.97M

    Net Cash

    n/a
    		 -3.22M

    Retained Earnings

    n/a
    		 -1.39B

    Total Assets

    n/a
    		 175.97M

    Working Capital

    n/a
    		 79.93M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 31.47M and capital expenditures -36K, giving a free cash flow of 31.43M.

    Operating Cash Flow

    n/a
    		 31.47M

    Capital Expenditures

    n/a
    		 -36K

    Free Cash Flow

    n/a
    		 31.43M

    FCF Per Share

    n/a
    		 1.79
    Full Cash Flow Statement

    Margins

    Gross margin is 89.6%, with operating and profit margins of 13.49% and 9.75%.

    Gross Margin

    n/a
    		 89.6%

    Operating Margin

    n/a
    		 13.49%

    Pretax Margin

    n/a
    		 10.24%

    Profit Margin

    n/a
    		 9.75%

    EBITDA Margin

    n/a
    		 15.9%

    EBIT Margin

    n/a
    		 13.49%

    FCF Margin

    n/a
    		 17.53%

    Dividends & Yields

    RIGL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 5.91%

    FCF Yield

    n/a
    		 10.63%
    Dividend Details

    Analyst Forecast

    The average price target for RIGL is $24, which is 17.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $24

    Price Target Difference

    n/a
    		 17.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 2.05

    Graham Upside

    n/a
    		 -89.95%

    Stock Splits

    The last stock split was on Jun 27, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jun 27, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -7.09

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist